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Earlier experiments from our labo rato ry revealed that the 
r:<ed ica tion most common ly used for depig menting pa-
tlents w ith vitili go, monobenzyl eth er of hydroqu ino ne 
(MBEH) , w hen applied to the skin ofDBA/ 2 mice caused 
a.n in crease in the population density (cell s/ mm 2) of iden-
~Jfiabl e la + and ATPase + Langerhans cell s. Further, this 
Increase in Langerhans cell densit y could be co rrelated w ith 
an in crease of contact hypersensitivity (CHS) reactivity to 
dinitrofluo robenzene (D NFB). The current experim ents 
demonstrated that o th er com pounds chemica ll y similar to 
MBEH, such as butylated hyd roxy toluene (BHT) and bu-
ty lated hydroxyaniso le (BHA), w hich are used as preserv-
atives/antioxidants in many topica l medications , cosmet-
ics, food , and rubber products, can in five days significantly 
Recentl y a new class of ceUs distin gL.li Shed by the pres-ence o f Thy-1 membrane g lycoprotein has been de-scribed in the epidermis of mice 11 ,2]. The T hy-l + dendritic epiderma l cells (Th y-1 + DEC) are deri ved from bo ne m arrow and see m to represent a heter-
ogenous population in that they may be dendritic o r round, and 
som e but no t all express other cell surface m arkers in addition to 
the Th y-l marker [3 ,4]. Th y-1 + DEC do not appear to be B 
lymphocytes , mon ocy tes, m acroph ages, o r pigment cells . The 
express ion of L3 T 4 + on cu ltured T hy-I '" DEC suggests that the 
cells are of pre-T-cell lineage [5 j. The presence of cell surface 
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Abbreviat ions: 
BHA: butylated hydroxyaniso le 
BHT: butylated hydroxy toluene 
C HS: contact hypersensitivity 
DNFB: 2,4-dinitro-1-Allorobenzene 
LC: Lan gerhans cel l 
MBEH: monobenzyl ether o f hydroqllinonc 
PT: Borde/ella perll/ss is toxin 
PTBC: paratert butylcatcchol 
Thy-I + DEC: Th y-I + dendriti c epiderm al cell 
increase the popul ation density of Thy- l + dendriti c epi-
derm al cell s. These com pounds had no effects o n la + cells. 
This observation suggests that the Th y-l + DEC cells may 
be m ore mobile and /or their surface markers m ay be readily 
expressed and are not a slowly mobile (trafficking) pop-
ulatio n of cell s as su gges ted by the results of previous work. 
In addition, these parasubstituted phenolic co mpounds be-
haved like pertussis toxin and induced T hy-l and la expres-
sion on keratinocy tes. These chan ges in Thy-l immune 
markers were not acco mpanied by functional alterations in 
the immune response to contact all ergens as m easured by 
the ea r swelling technique. J Jll lles t Dermato/ 89:489-494, 
1987 
m ark ers normall y found on natural killer cells (NK) , i. e. , asia lo 
GM-1 , has led some inves tigato rs to speculate Th y-1 + DEC are 
NK cells of the skin [31. Other in ves ti ga tors have proposed that 
th e Thy-1 + DEC are epiderm al suppresso r cell s [6]. The precise 
fun ctio n of th e Thy-1 + DEC is not known , but beca use it is 
presum ed to be of T-lymphocyte lineage it is believed to play 
so me role in the cutaneous immune respo nse. 
The othe r epiderma l immune cells, Lange rh ans cells (LC), are 
13 positi ve epiderm al immune m acrophages, w hi ch are necessa ry 
for initiating T-l ymphocy te sensiti za tion to anti gens, includin g 
those that ca use allergic contact dermatitis (ACD) [7-10]. The 
quantity of C lass II major hi stoco mpatibility complex (MHC) 
antigens la/ HLA-DR on these accesso ry cell s appears to be one 
m ajo r determin ant for the intensity of var ious immune responses 
including the contact h ypersen sitivity response [11-14]. 
Seve ral pheno ls, specifi ca ll y 1110nobenzy l ether of hydroqui-
none (MBEH) and paratert butylcatecho l (PTBC), are co mmonl y 
used as medications to depig m ent pati ents with vitili go, but are 
also used as antioxidants and are in gredients found in rubber , 
plastic , and germi cidal solutions. Both of these agents m arkedl y 
in crease the population density (celiS/111m2) and /or en hance 
expression of la/ ATPase positive markers on Langerhans cells in 
murin e <: pidermi s [14,15]. These sa me phenols g reatly exacerbate 
contact hypersensitivity rea cti ons (CHS) in mi ce, possibly as a 
result of enh anced expression of la [1 4]. 
Other co mpound s, chemica ll y simil ar to MBEH, are used very 
co mmonly as prese rva ti ves/antioxidants in to pi cal medica tion s, 
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fo'ods, and cosmeti cs. Th e present stud y was undertaken to de-
termin e w het her topica l app li cat io n of so m e of these m o re ubiq-
ui tous co mpo und s, nam ely but ylated h yd roxyto lucne (BHT) and 
butylated h yd roxY:lI1isole (B HA ), like MBEI-I. co uld :d ter the 
dens ity, functio n , and ex press io n of 13 ' LC o r Thy-I + DEC or 
ca use in creased exp ress io n o f la and Th y I o n kcrat in ocy tes. Sev-
eral in vestigators have shown th a t BHT has dram ati c effec ts on 
splenic im mun c cc ll s in vitro [ 16-19 [, but its ro le o n th e cu ranco us 
immune respo nse remain s unknow n. Wc fo und rhar B HT and 
B HA affected the popu lation o f T h y-I ' DEC but not th e la' 
cell s. 
It has been shown by others tha t keratin ocy tes in a va rie ty of 
derma topath o logic s ta tes and und er certain cx perim cntal condi-
ti o ns ca n exp ress H LA-DR / Ia alltigenic m ark ers [1 2, 13,20 ,2 1]. 
Butylated hyd roxy toluene and BHA alsu indu ced in creased 
exp ress io n of Thy- I o n ke ratinocytes. These changes in Th y-I ' 
DE occurred mu ch m o re rapi d ly tha n p redicted by the results 
of prev io us wo rk [22]. 
MATER IALS AND METH O DS 
Animals Fo ur- to six- week-o ld ma le DBA / 2d , C57BLl6il , and 
Balb i d mi ce were p urchased fro m the J ackson Labo rato ry (Ba r 
H arbo r, M ain e) and we re ho used in the Uni versity animal fac il-
iti es fo ur to six per cage w ith free access to wa ter and Purina 
m o use chow. T he anima ls were exposed to an ambient 12 h li g ht: 
dark ph o to period . 
Identification of Epidermal Ia + and Thyl + Epidermal 
Cells BrieAy, ca rs we re surg ica ll y excised from ethe r vapor 
sacrifi ced mi ce. Th e ea rs wc re m echani ca ll y sp lit in to do rsa l an d 
vcntral halves. Do rsa l hal ves we re imlll c rsed in 0.02 M Na EDT A 
fo r 2 h at 3rC. The epidermis w as se parated as an intact shee t 
frolll the under lyin g derm is [1 4[. Ep iderma l specime ns o btain ed 
fro m th e ba ck were prepared as described pre vio usly [ 14 [. 
Epide rm al sheets were stain ed fo r Ia and Th y-I anti gens as 
follo ws. The ti ss ue was fix ed in ace to ne o r co ld 95% e thanol for 
20 min fo llowed b y a 1-h wash in PBS a t roo m temperature to 
reh ydrate the ti ss ue. Specim ens were then s tain ed w ith appro-
pri ate m on oclonal antibodies. MK.D6 (prepa red by J o h n Kap-
pler, Uni versity of Co lo rado at Den ver and generously provided 
as a g ift from R. Daynes , Departlllent of Patho logy, U ni vers it y 
of Utah) stains for ani-Ad determinant. The m o no cl o n al antibody 
anti-I-A " (Accurate C hemi ca l and Scientifi c Co rpo rati on , West-
bury, New Yo rk) is specifi c for I_ Ail determin ants. The m o no-
clon al antibo d y Th y-I. 2 (Accu rate C hem ica l and Scientifi c Co r-
poration) s tain s an tigen coded b y the Th y-1. 2 subset of alle les. 
Ti ss ue was in cubated w ith the primar y antibo d y for I h at 37°C 
foll owed b y ex tcnsive washin g in PBS . An indirect immuno-
perox id ase s ta inin g m eth od cm ploy in g a Vectas tain A vidin Biotin 
Kit (Vector Laborato ries, Burl ingamc, Ca lifo rnia) us in g 3- amino-
9-e th ylcarbozo le (S igma C h emi ca l Compan y, St. Lo uis. Mi s-
souri ) as the stainin g subs[ratc was uscd as descri bed previous ly 
[23 1. Fo r contro ls in all experim cnts, the specifi cit y o f the im-
mun o perox idase reactio n was tested by o mittin g th e p rim ary 
ant ibody and sta inin g d irec tl y w ith the secondary antibody. Al-
th o ug h we were limited rechni ca ll y in term s o f absolu te p recision 
using our imillun o hi stochemica l stainin g techniq ue (i.e. , we could 
not dem onstratc abso lute loss o f stainin g w ith removal o f the 
primary antibodies), the results were consistent and dramatic w hen 
co mpared with sta ined trea ted and con tro l (d iluent) epidcrma l 
specim ens. 
Thc den si ty of the id entifiable la + and Th y-I + DEC w ithin 
each epidermal sheet was determined usin g a Leitz Dialux li ght 
mi croscope wi th a ca librated eyepiece. The number of la + and 
Th y-l + DEC per 111m2 in four stan dardi zed peripheral areas of 
each epid erm al sheet we re determin ed. At leas t four animals were 
studied in each g ro up . Thc repo rtcd Th y-I ' DEC density for 
each sheet represen ts th e mean o f at leas t 16 counts ± standard 
er ro r. 
TI-IE JOU RNAL OF INVESTIGATIVE J)E I~MATOLOGY 
Topica l BHT and BHA Administration A series of pilot 
expe rim ents was performed a t va ri ous co ncentrat io ns to deter-
min e the effec ts of the specifi c pheno ls BHT and BHA . The 
solu tions ofB HT and BHA were prepared co nta inin g 0.00 1, 0.01. 
0. 1, 1.0, 5, o r 10 g/dl. The ma x imum effects were produced by 
solutio ns of BHT 0 .001 g/dl and of BHA I g/dl , and th erefore 
these con centration s were used throu g ho ut all studies. A ll studies 
we re perfo rm ed two o r m o re tim es pro du cing s imilar results. 
The concentratio ns used were relati vely cO lllparable to those found 
in m an y topica l medi ca tio ns and foods [24 ,25 [. 
Mi ce were trcated o n days I thro ug h 5 b y topica l appli cation 
o f13HT 50 J.LI of 0.001 g/dl (0.5 J.Lg / app li ca ti o n). Other mi ce wcre 
trea ted w ith BHA , at 1 g/dl (0 .5 m g / applicat io n). C ro ups o[m ice 
we re treated w ith o nl y o ne of th e co mpou nds app lied cither to 
the do rsa l surfa ce o f the ca r o r to the shaved back . Th e control 
mi ce received th e d ilu en t (95% ethan o l) applied to th e ap propri ate 
site. On day 6, sk in bi o psies were o btai ned and th e population 
density ce ll s/ m11l 2 o fL C and Thy-I + DEC was determi ned . Dou-
ble s tainin g was not utili zed in an y of the imlllun o his tochemi cal 
studi es perfo rm ed . 
Mono ben zyl e ther of h ydro q uino ne was dissolved in 95% crlunol 
at a concemration of20 g/d l. This is the s tanda rd co mlll ercia ll y 
ava ilable co ncentra ti o n (Benoq uin , E lder Co. , Brya n , O hi o), al -
th o ugh extensive dose responsc studi es have been repo rted by us 
ea rli e r li S], 
Pertussis Toxin (PT) Bo"dc(cllll pCl'fIlSSis tox in lor #PT-II \Va 
o btai ned fro m List B io log ica l Labo ra to ri es (Ca mpbell , Califor-
nia ). Purity of the tox in was assessed by sodi um do decy l sul-
fate-po lyacrylamide gel elect ro ph ores is (SDS-P ACE) and it \\'a 
supplied in 50 J.Lg/ml vial s. Mi ce trea ted w ith PT received 100 
ng o f pure tox in (as described prev io usly [1 3 J inj ected I V (tail) 
24 h bcfore s tainin g fo r la + and Th y-I ' ant igen. 
Contact Sensitivity and Challenge Mi ce were sensiti zed and 
challen ged usin g an ca r swcllin g assay with DNFB as described 
previous ly [1 4 [. 
Statistics Stati stica l s ign ifi ca nce of diffe rences between treat-
m ent and contro l g ro ups was calcul a ted us in g a Student 's ( test. 
M ean differences were considered signi ficant w hen p was less 
than 0 .05. 
RESU LTS 
Effect of Topically Applied BHT and BHA on Epidermal 
Ia + and THYl + DEC Fifty l11i cro liters o f 0.00 1 g/dl (0.50 
J.Lg/dosc) o f BHT, applied fo r five da ys to pinna l epidermis of 
C57BLl6 mi ce, did no t pro du ce sig ni ficant alte rat io ns in the num-
ber of la ' LC (da ta no t show n) . After fi ve days of treatment. 
howeve r , th ere was a sig nifi ca nt in crease (49'1'0) in Th y-I + DEC 
(t = 10 .057 ; P < 0.(01), co mpared with di lu ent treated controls 
(Ta ble I). Hi gher concentra tio ns, 0.01 g/dl o r g reater , produced 
no signifi ca nt chan ges in number of la + o r Thy-I + DEC on the 
ca r (data no t shown) . Hi stolog ic eva lu ation of trea ted epidermal 
spec il11ens did no t reveal ev idencc of tissue injury, inAamm ati on. 
o r m o no nu clea r infiltrate (Fig 1). 
BHA (I g/dl) (0.5 m g / appli cat io n) afte r five days of app li cation 
produ ced a 23% in crease in Th y-I ' DEC density in pinnal ep-
idermis (t = 2.20; p < 0.05) (T abl e I). Similar densi ty change 
in Th y- 'I + DEC cell s were o btain ed fro m epidermis fro m the 
backs o f se parate ly treated mi ce (Table I) . BHA at 0 .5 m g ap-
pli ca tio n d id prod uce a 22% in crease in Ia + LC (da ta no t shown). 
Lower doses of BHA had no signifi cant effects on either cel l type 
(data not sho w n). We con clud e th at these co mpounds can alter 
the dens ity of Th y-I + DEC ccll s at a relatively rapid r ate. 
Reactivity of the Contact Hypersensitivity Response Fol-
lowing Topical Treatment With Antioxidants In ea rlier 
studies, we demonstrated th at DBA / 2 mi ce treated w ith MBEH 
11 4. 15J had an in creased number of id entifi ablc Ia + and ATPase ~ 
LC b y 50-70% [1 41 . Th is differen ce appea red to co rre late with 
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Table I. Mean N Ulll er ica l DCll sity of T h y I + Pos iti ve 
Ccll s / lllll1 ~ ± SE M o n Pinn a l o r D o rsa l Ep idermis of 57B Ll6 
M1 CC T rl'a ted T o pi ca ll y fo r Five I ays W ith B u ty l:!ted 
H ydroxy to luen e (B H T ) o r 13uty lated H ydroxya nisolc ( l31-IA ) 
Compound Dose Applied Sire T hy l + cdls/ nllll } 
B HT O.50 /-Lg lll Eel I' 67 1 ± 2 1 ** 
dil llelH (<)5 % ETO H) Ea r 4-1H ± I I) 
1).50 /-Lg lll l3 ack 3H2 ± 25':"" 
dilll clH (1)5 %, ETO H) 13:1ck -I3() ± ? -
BHA 
_J 
O.S lll g Eel I' 551 ± 25 ':' 
dilul'Ilr (95 % ETO H) E:Jr -I-I H ± 1'.1 
U.5 111 g l3:J ck 565 ± ? - * _J 
dilucnr (95% ETOH) l3:lck -142 ± '2H 
:~ < 0.0.1 comp.l fL'd w ith d ilUl' lIl (CJ5 i yu ETO II) cOllt ro l ;lIlim als. 
I' < 1J.()OI cO lll l'arl'd w ith dilu(' J1[ (')5% ETOH) colll ro l all illl:)l> . 
1? :uJ rq >rl'sl' lI( till.: 111 1..':1 11 Illlllll..'ri c:d dC ll s i( v (cl..' lI s/ Il1 11 1!) (ro m t wO co mhincd 1..'.'.:-
pC rlll1 l..' ll. t ~ . ~ l11i n:ltr i:d :t SEM . G rol1p~ or ;ll icL' w a c.: lrc.ltL'd sl..'par.ltd y 0 11 car o r 
bJck t'pH.krnl.1l ~ i { L' !'I. 
e nhan ced Con tact h ype rs~n s i t i v i ty reacti v ity ro DNFB and OX ;1-
zo lon e 114J. After trea tm cnt with BHT and B H A, wc collta ct 
sc n s itizcd C57B Ll6 mi ce to DNF13. W e fo und no s i g nifi c~ nt dif-
fc re nccs in C H S react iv ity w ith an ear swellin g assay cO lllpa red 
WIth Ollr di lucnt co ntro ls (da ta not shown) . This obscr va tio n is 
con SIStcnt wi th th e conccpt th at illlI11un e reactivit y is dete rm incd 
III p art b y la exp rcssion. O nl y B H A prod uced a ve ry s li g ht change 
III LC dcnsity o n ca r ski n and th e refo re wou ld no t bc cx pectcd 
to prod uce m ajo r fun c tio nal chan ges in immune rcsponsiveness. 
Effects of MBEH on Thy-1 Dendritic Epidermal Cells In 
o ur. ca r li n s tudies wc repo rted th a t D13A / 2 mi ce de lll o nstratcd 
an 1l1 CrCase in A TPasc + and fa I LC fo ll owin g a 20% MBEH 
trcatm cnt 11 4 1. 13cnoq uin o r MBEH in thi s co nccmrat io n is a 
s tanda rd cO llllll e rciall y available pro du ct. Others have shown that 
DBA/2 and Ba lb/C mi ce possess a paucity of res idcm Th y- I I 
DEC CO l11pa rcd w ith la I LC 12 1. To determin e w het her the pop-
ulatIon o f Th y-l I DEC was gcnc tica ll y rcs tr ictcd, we t rea tcd 
thcsc two st rains o f mi ce, alo ng with C57B Ll6 mi ce w hi ch had 
a g rea ter rcs ident pop u lation of T h y-I ' DEC, w ith MBEH to 
dcte rminc its po tcmi a l cffect o n this ce ll population. DBA / 2. 
Balb /e, and C57 13 L16 mi ce werc treated fo r fIve days wi th 5U ,u.1 
of 20% MBEH :l ppli cd to thc pi nn :l l epidermis and T h y-I I DEC 
~c lJ s wcre qualltified . Therc were in creases in the density (ce ll s/ mm ") 
III Th y-I ; DEC fo ll owin g MBEH t rea tm cn t in all three s tra in s 
o f mice. DBAI2 mi cc trca tcd fo r fIve da ys w ith M13EH de m -
o n s t rated a 42% increase in T h y-1 + DEC (t == 2,09, p < 0.(5) 
,-
F ig ure 1. Hisro logy of rhe car afrer fi vc d:lYs of rop ical app li ca ri on wirh 
0.00 1 g/dl of I3HT. Thc car d isplays 11 0 Ill ononuclea r ccll infi lrrare wirhill 
the d o rsal dermis o r epidcrmis or oth er ev idencc of inAam lllarion. (H&:E, 
Y6(0). 
I(A I' I )) IN I UCTION OF T H YL ANTICEN IC MARKERS 491 
Tab le II . Ml'an Num eri ca l Dcns it y of Th y I PosiJ:i ve 
Cell s/ ml11 ~ ± SEM o n Pinn a l Epidcrmis o f DBA /2, Ba lb /C. 
and C57BLl6 Mi ce T rea ted Five Days T opical ly With 
M o no bcnzyl Ether o f H yd ro qu il1 o ne (MB EI-I ) 
T h)' l + DEC 
cells/nlll1 } 
Sire Dosc ± SE % C h:ln gc 
D13A /2 E:1I' 20% M I3EH 153 ± 1-1 * 
di lllcnr (1)5'X) ETO H) I OH ± 15 ...J2 °!cJ 
Ih lb /C Ea r 20%, MI3EH 13-1 ± I I" 
d illlclH (<)5% ETO H) 70 ± H 1) 1% 
C57 1l Ll6 E:l r 20 'Yo MI3EH -1 2-1 ± 35* 
dilllclH (95'10 ETO H) 2-15 ± 2-1 73''10 
*1' < fI .05 (O lllp.ln .... d w ith dilul'n t ( )5 <}~1 ET O II) cOlHfol :lIlilll:1l s. 
1),ILl r c prcs l' lH the 1ll l':1 11 Iltllll Cri c;l i (kll ~ it y (Cl' Il S / Ill1l1 ~) li'o m IwO (o lli bill l'd l'X-
pail1l L' lIh . 4 Ill icch ri:d :!: S ENt. 
versus o ur d ilucn t co ntro l mi ce. 13a lb / C mi cc treated w ith MBEH 
dem o ns trated a 91 'Yo i n c re~sc (t == 4,63; J! < (l .OD I) in T hy-I ' 
DE versus o ur di luent contro ls. C57 BLl6 mice t hat possess the 
hig hest res idcllt T h y-I ' DEC dens ity (ce lls/ I11I11") responded w ith 
~ 73% in c re~se in Th y-I ; ce lls fo ll owin g M13EH trea tm cnt co m-
parcd w ith eth:ln o l co ntro ls (t == -1. 27, P < 0.0( 1) (T~ blc 11) . 
Altho u gh the abso lutc numbers of T h y-I ' DEC in trcatcd o r 
ulltreated a nim~ l s sce m cd to be a g l'1l c ti ca ll y dete rm ined v~ riab l l', 
the pc rcl'nrag e cha ngc in T h y- I ' DE was gre~tc r fo r the 13a lb/ C, 
w hich h ~l d the lowest baseli nc pop ul a ri o n , 
BHT, BHA, and MBEH Induce Thy-l Antigenic Markers 
.oil Keratinocytcs W hcn we stained our trea ted epide rm al sheets 
fo r T h y-I I DEC, we no ted intensc fo ca l sta inin g of ke rati nocy tcs 
fo r T h y-I ; J llti gcnic nurkers (Fi g 2). Contro l expni m en ts of the 
stain in g techniqu c appearcd to ru le o ut no nspcciti c CIldogcll o us 
peroxidase ~ct i v it y as p rod ucin g thc o bsc r ved ctl;':ct. Fi g urc 3 
shows T h y-I ' DEC in untrcated skin. T h y-I I dendr it ic ce ll s a rc 
vis ible and the re is s li g h t s ta inin g of the kcr~ti n ocy r l's. Fig urc -I 
shows MBEH trea tcd skin s tain cd w ith th e seco nd anti bod y in 
perox id :lse w itho u t p ri o r exposure to t he Th y-I p ri m ary anti-
body. Notc the dramat ic decrcase of s rainin g o bserved eithe r o n 
dend riti c ce ll s o r kcrarinocytes w hen co mpared w ith Fi gs 2, 5, 
and (l. Fi g ure 5 shows MBEH t re~ ted ski n s ta in cd with th c pri-
Figure 2. Focal T hy- I C :l IHigcn sraini ng or kcrarinocyrcs (ar row) ob-
raincd fro Il 1 pinna l ep ide rm al shccrs ofC57 I3 U() mice followill g fiv c da ys 
of ropi c:l1 rrCa till clH wi rh 13 HT. An illdi rccr illl nlllno perox idase Ill crhod 
was uti lized. (low power X 32). 
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Figure 3. High mag ni fication 0(;111 untrea ted indirec t imlTlu noperox idase 
stained Th y-I ; DEC pinna l epidermal sheet fro lll a C57DLl6 mouse. 
Note the absmcc of il1tense stainin g of Th y-I on kcratin ocy tes (x 256). 
m ary and secondary antibody . Th ere is an in creased num ber of 
Th y-l ·1 DEC and in creased ex press io n ofTh y-1 staini ng a ro und 
th e kera tin ocytes . T he immediate sig nifi ca nce o f these fi ndin gs 
is unkn own, altho ug h enh anced ex press ion o f Th y- I antigeni c 
m arkers apparcntl y ca n be simultaneo usly exp ressed o n kera t-
in ocytes and dendriti c epid erm al ce lls fo llowin g five da ys of top-
ica l trea tm ent w ith va ri o us antiox id ant co m po un ds . 
Effects of Pertussis Toxin on Ia and Thy-l Antigen Expres-
sion b y Keratinocytes It is kn ow n th at in a va ri ety o f der-
Ill atopath o logic conditi ons , keratin ocy tcs can exp ress HLA-DH 
anti gens [20,21 J. Al so, in cubati o n of keratin ocytes w ith y inte r-
feron ca n rcs ult in de novo sy nthes is of thc la/ HL A-DR MH C 
gene prod u cts [2ol . 
A recent repo rt by Hobcrts and associates [1 3 1 de l1l o nstrated 
signifi ca llt co rrelati on between keratin ocy te ex press io n of Ia and 
illten sity / d ura tio n of C HS in l1Ii ce receivin g injectio ns of Bor-
de/ella per/I/ssis toxin. We repea ted those studi es confirmin g la 
ex press io n o n kerat in ocytes in C57BLl6, B alb/ C , and DBA / 2 
mice fo ll owin g pertu ss is tox in trea tm ent. W e noted , however, 
that o ur epiderm al speciJl1 ens fro Jl1 pertu ss is trea ted anim als 24-
h pos t inj ection dcm o nstrated intcnse foca l s tainin g fo r Th y-I o n 
kera tin o cytes as well (Fig 6) . Althoug h o th ers have repo rted tint 
untreated kerat in ocy tes ca n ex press sm all am o unts o f ba ck g round 
Th y-I anti gen , they did not obse rve intense stainin g 11 ,4,5,27,28 1. 
Appropriate contro l experim ents w ere per fo rmed d urin g the in-
d irect immuno perox idasc stainin g tcchnique. Ti ssues were in-
cubated in th c absen cc of primary or second ary antibodies and 
o ther stainin g in g redicnts. Results confirmed b y lig ht micros-
cop y, alth o ug h not absolute ly d efiniti ve, were consistent w ith 
thc fac t th at express io n of Th y- 1 o n kerat in ocy tes co uld no t be 
attributed to no nspecifi c depositi on of stain in th e indircc t im-
Illun ope rox idase s tainin g assay (Fig 4) . T he intense s tainin g o f 
Th y-1 anti gen o n the cubo id al ce ll s precluded us fro m m ak in g a 
definiti ve quantita ti ve o bserva ti o n o f th e density of Th y-I + dcn-
driti c ce lls in pertuss is treated anim als. 
D ISC U SS ION 
Anti oxida nts/ preserva ti ves such as B HT and B H A arc ubiquito us 
ph eno li c com po un ds used in th e m anufac ture o f ph arm acc ut ica l, 
cos m cti c and foo d prod u cts. Alm o st all cos m etic and topica lmed-
ica tio ns contain one o r m o re of these anti oxida nts o r a ve ry simil ar 
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Figure 4. High magnifi ca tion of an epiderma l shcct from a C57 B Ll6 
mouse treated fo r fi ve days wi th a dose of 20% MI3E H. The primary 
anti T hy- I.2 allti bod), was exclu ded, and olll y the seconda ry biotin con-
j ugated anti bod y along with the staillin g perox idase substrate were added. 
Note the decrease of positiw staining of either Th y-I ; DEC or kcrat-
illocytes. O nl y nonspeci fi c ell dogenous peroxidase staini ng of the pi lo-
sebaceous glands of the hair fo lli cles staillcd intensely (x 256). 
agent. Th eir effcc ts in vitro on sys temi c immune res po nses have 
been docum en ted. These co m po un ds ca n suppress L3T -+ (Th) 
ce ll s, in crease Lyt2 + (T s) ce ll s, and suppress m ac ro ph age ph ago-
cytosis w hen o btaincd fro ll) m o use splenic ce ll preparations 11 6-19]. 
Thcir po tenti al role in a ltc rin g the periph eral o r epidermal im-
mun e response fo ll owi n g en v iro nm ental ex posure, however, has 
not bcen exa min ed ex tensively . In ea rli e r studies, we demon-
strated that topical application o f the parasubstituted pheno l MBEH. 
ava ilab le by prescription fo r trea tm ent o f pati ents w ith vitiligo . 
could increase the dens ity of identifiable la ' LC [1 4,15] . This 
in crease in th c LC densit y co uld bc co rrel ated w ith enhanced 
afferent and efferent cutaneo us immune reacti vity using va rio u 
haptens/a lle rgcns (D N FJ3 and oxazo lo ne) [141 . 
Figure S. High magnifi ca tion of a pinnal epidermal sheet from a DBAn 
mouse topica lly trea ted for fi ve da ys with 20% MBEH and stained with 
Thy-1. 2. Note the apparent in crease in densit y of T hy-I + DEC and the 
enhanced focal staining of keratinocy tes fo r Th y- I (x 256). 
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Figure 6. Pinn al epidcrn131 sheet obtained fro ll! a C57J3 L16 Illouse 24 
hours POS t injecti on of Borderel/a pertllssis toxin stained with Th y-I. 2 an-
nbody. There is intense foca l stainin g of cuboida l cells fo r the T hy-I 
ma rker. The Th y-I + DEC are dcnoted as well (a rrows) (indirect im-
mu noperox idasc stainin g X 256). 
In th e present stud y, we expanded the sco pe of o ur in ves tigati on 
o f e nvironm ental anti oxid ant co mpo und ex pos ure and its ro le in 
alte rIng th e C H S response in mice . C 57B Ll6 mi ce receivin g to p-
ICal treatments o f BHT o r BHA dem o nstrated in co nsistent and 
very small in creases in th e density o f la + dendriti e LC at vario ll s 
eplderm al sites . Enum eration o f the Th y-1 + DEC o n trea ted 
epiderm al s ites, however, co nsis tentl y revea led a sig nifi ca nt in-
crease in the density (ce lls/ 111m2) o f th ese d endritic ce lls . Thi s 
occurred rapidly , w ithin fi ve d ays . The anim als trea ted either o n 
the back o r ca r skin res po nded no rm all y to th e contact a llergens. 
~ar swellin g is a relati vely crud e assay. T he results o f the fun c-
nona l studies, howeve r, do no t suppo rt th e concept that th e Th y-
1+ DEC arc suppresso r cells. 
O th er inves ti ga to rs have repo rted that va ri o us murin e strain s 
possess sig nifi ca nt diffe rences in the d ensity o f identifiab le Th y-
1'" D EC at va ri o us epid erm al sites versus LC densit y [2]. In the 
cu rrent ex perim ents, we dem o nstrated th at MBEH co uld also 
sign ifi cantl y in crease the density o f Th y-1 + cells in mi ce strains 
possess ing few res ident Th y-1 + cells. 
I t is kn own that y interfero n appears to be o ne o f m any po tenti al 
? iologic m olecules capab le o f indu cin g la ex press io n on kerat-
Ino cytes [26]. We fo und , as did others [13], that pertussis toxin 
can result in la antigen ex press io n o n keratinocy tes . W e fo und it 
also ca uses in creased ex press io n o f Th y-I on keratin ocy tes. Per-
tuss is- trea ted anim als react v io lentl y to contac t allergens (Dr. Lee 
K. Roberts, Uni versity o f Utah , personal co mmunica ti on). The 
cu rrent studies dem onstrate that m o re ubiquitous env ironmental 
che mi ca ls w hen to pica ll y appli ed can res u lt in not o nl y alterati ons 
in th e density of epiderm al Th y- l + immune cell s, but in additio n 
res ult in enhanced ex pressio n of the Thy-l antigenic m arker o n 
kerati nocy tes . They do not altcr res po nse to conta ct a lle rgcns. 
Ea rli cr studies b y o thers using chim eric semi allogcneic skin 
g rafts 122] de m o nstrated that Th y-l + DEC immig rated into d o-
no r ti ss ue very s lowly, ove r a perio d of severa l m o nths, befo rc 
reach in g m o derate density. It was sugges ted this po pula tio n o f 
cell s was ra th er ind o lent w hen co mpared w ith Langerh ans cells. 
In thc current studies, it appca rs th at parasubstituted pheno ls and 
pertuss is toxin could indu ce a sig nifi ca nt in crease in th c Th y-l + 
DEC density (ccll s/m m 2) and T h y-l antigen ex press io n in mi ce 
possessin g bo th large or relati ve ly few resid ent Th y-l + DEC cclls 
fo llowing just fi ve days o f epi cutan eous trca tm ent. In o ur ca rlier 
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studies [14J , we repo rted that MB E H cou ld alter th e density of 
la cx pression o n identifiab le Langerh ans ce lls and enh anccd th e 
C H S res po nse. Further, th is effec t co u ld be totall y repro du ced 
usin g a relevant bio logic m o lecu le, arachid oni c acid . It is con-
ceiva ble that arachid o nic ac id , eith er d irectl y or indirec tl y thro ug h 
arachid o nic acid m etabo lites (i. e., prostag landin s, thro mboxa nes, 
and lcuko trienes), m ay alter th e ex press io n of Th y-l anti gen o n 
cpiderm al ce lls fo ll owin g ph eno l ex pos ure to BHT and BHA. In 
vitro ex perim ents are currentl y un derway in w hi ch epiderma l ce ll 
suspensio ns are ex posed to the above m o lecules (BHT, BHA , 
ara chid oni c acid and its m etabo lites) and the density o f the T h y-
1 m o lecule determin ed usin g flu o rescent mi cro fl ow cy to mctry. 
Further, th ese co mpo unds mig ht serve as a chem oa ttracta nt to 
precurso r Th y-l + DEC cells that m ay reside in the dermi s o r are 
circu lating , w hi ch can then immig rate to the ep idermi s in re-
spo nse to an appro pria te stimulus . On the o ther hand , these sub-
stan ces mi ght altcr cell cy cle tim es and indu ce mitosis, o r cou ld 
alter ex press ion o f o th er cell surface markers 14] . An other ex pla-
natio n is that th ese agents alter the epiderm al microen viro nm ent , 
thereb y a ll owin g th ese cells to m ature in an cx trath ymi c en vi-
ro nmcnt [29]. Studics are currentl y underway to begin to address 
so m e o f th ese iss ues in o ur labo rato ry . Alth o ugh we d id not no te 
an y gross changes in C H S respo nsiveness followin g BHT and 
BHA treatm ent as occurred in our ea rlier studies w ith MBE H , 
the ea r swelli ng assay might no t be sensitive eno ugh to deno te 
subtle yet sig nifi ca nt fun cti onal chan ges in la + o r o thcr epiderm al 
immune cell s fo llowing to pi cal antiox idant trea tm ent. C urrentl y, 
mi xed epiderm al lympho cy te reactio ns (MELR) are und erway to 
determin e m o re precisely the ro le thesc compo unds mi g ht have 
on immune fun ctio nal ca pabilities o f epidermal immune ce ll s fo l-
lowin g in vitro trea tm cnt. 
The fact that co mm o n env ironm ental ph eno ls, MBEH , BHT 
and BHA, appea r to indu ce la and in crease ex pression o f Th y- l 
o n keratin ocytes and alter the density o f l a ~ LC and Th y- 1 + 
D EC m ay have impo rtant consequences as fa r as imllluno to xi-
cologica l effects of chro ni c exposure of these co mpo unds on th e 
skin. C lca rl y, further studics are needed to assess Ill o re precisel y 
the in terrelationship o f la/Thy-l bo th pheno typicall y and fun c-
ti onall y in in vivo and in vitro assays. 
Tlt e alllit ors are gralcjiti to M~ . J OO II C r(rzgs fo r lit e excel/ fil l Iypillg of lit e 
lIIallll scripl. 
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